首页> 外文OA文献 >ANTI-TUMOR ACTIVITY OF DARATUMUMAB, A NOVEL HUMAN ANTI CD38 MONOCLONAL ANTIBODY, IN IN VITRO AND IN VIVO MODELS OF B-CELL NON-HODGKIN LYMPHOMA

【2h】

ANTI-TUMOR ACTIVITY OF DARATUMUMAB, A NOVEL HUMAN ANTI CD38 MONOCLONAL ANTIBODY, IN IN VITRO AND IN VIVO MODELS OF B-CELL NON-HODGKIN LYMPHOMA

机译：达拉姆姆人，一种新型人抗CD38单克隆抗体，在体外和体内模型的B细胞非霍奇金淋巴瘤中的抗肿瘤活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P. Pérez-Galán; A. Vidal-Crespo; A. Matas-Céspedes; V. Rodriguez; C. Rossi; G. Roué; A. López-Guillermo; E. Giné; E. Campo; D. Colomer; A. Wiestner; C. Bezombes; S. Balasubramanian; C. Chiu; P. Doshi;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens [J] . Anna Vidal-Crespo, Alba Matas-Céspedes, Vanina Rodriguez, Haematologica . 2020,第4期

机译：Daratumumab在B细胞非霍奇金淋巴瘤模型中展示体外和体内抗肿瘤活性，并改善了对标准化疗免疫治疗方案的反应
2. Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines. [J] . Liu XY, Pop LM, Tsai L, International Journal of Cancer =: Journal International du Cancer . 2011,第2期

机译：嵌合，二价和四价抗CD19单克隆抗体，具有效力的体外和体内抗肿瘤活性，对人B细胞淋巴瘤和B前急性淋巴细胞白血病细胞系。
3. The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma [J] . Christian Beth A., Poi Ming, Jones Jeffrey A., British Journal of Haematology . 2015,第5期

机译：人源化抗CD74抗体milatuzumab和人源化抗CD20抗体veltuzumab的组合显示了在复发性和难治性B细胞非霍奇金淋巴瘤患者中的活性
4. Increased Anti-Tumor Efficacy In Vivo of Doxorubicin-Loaded Long-Circulating LiposomesModified with Anti-Tumor Monoclonal Antibody [C] . Tamer A. Elbayoumi, Vladimir P. Torchilin Annual meeting exposition of the Controlled Release Society . 2005

机译：抗肿瘤单克隆抗体修饰的阿霉素长循环脂质体的体内抗肿瘤功效增加
5. Characterization of Anti-Ricin Monoclonal Antibodies and the Construction of a Chimeric Murine-Human IgG2/K Anti-Ricin Monoclonal Antibody [D] . Vendramelli, Robert Matthew 2011

机译：抗蓖麻毒蛋白单克隆抗体的表征和鼠/人IgG2 / K嵌合抗蓖麻毒蛋白单克隆抗体的构建
6. Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens [O] . Anna Vidal-Crespo, Alba Matas-Céspedes, Vanina Rodriguez, 2020

机译：Daratumumab在B细胞非霍奇金淋巴瘤模型中显示出体外和体内抗肿瘤活性并改善了对标准化学免疫疗法的反应
7. 895P Phase I study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody MIL62 in Chinese patients with relapsed/refractory CD20-positive B-cell non-Hodgkin’s lymphoma [O] . Y-K. Shi, Y. Song, Y. Qin, 2020

机译：895P期I型研究结果II型甘油型抗CD20单克隆抗体MIL62中的复发/难治性CD20阳性B细胞非霍奇金淋巴瘤
8. Does Combination Immunotherapy with Human Monoclonal Antibodies Against HER2 and CXCR4 Augment Breast Cancer Killing in Vitro and in Vivo [R] . Marasco, W. A. 2007

机译：与HER2和CXCR4的人单克隆抗体联合免疫治疗是否会增加乳腺癌的体外和体内杀伤力

相关主题

ANTI-TUMOR ACTIVITY OF DARATUMUMAB, A NOVEL HUMAN ANTI CD38 MONOCLONAL ANTIBODY, IN IN VITRO AND IN VIVO MODELS OF B-CELL NON-HODGKIN LYMPHOMA

著录项

引文网络

相似文献

相关主题

期刊订阅